Entries by Maren Kühr

Building a new industry and medicine thanks to biotech

Biotechnology is helping us tackle challenges such as emerging diseases, the impact of ageing in healthcare, population growth, climate change, and the green transition of the economy. Precision medicines, advanced therapies, mRNA and gene editing technologies are transforming the way diseases can be diagnosed and treated, providing life-saving solutions. Biotechnology is also at the forefront of building a sustainable economy, developing better crops, providing new protein sources, and producing bio-based materials.

New CSO has started

London-based Engitix Ltd has appointed a new Chief Scientific Officer (CSO). Christopher Stevenson, Ph.D. took over the position at the beginning of September.

LISAvienna welcomes new team member

Eva Schlintl joined the LISAvienna team at the beginning of September. Most recently, she managed the LISA – Life Science Austria programme of Austria Wirtschaftsservice Gesellschaft mbH (aws).

New Executive Director of Innovative Health Initiative

The Innovative Health Initiative (IHI) Governing Board has appointed Niklas Blomberg to be the next Executive Director of the organisation. Dr Blomberg has extensive experience of working in Europe’s life science sector, and is currently Director of ELIXIR, the European life sciences data infrastructure. He will take up his duties at IHI in early 2024.